ZA906327B - A method for the treatment of cardiac and of vascular hypertrophy and hyperplasia - Google Patents

A method for the treatment of cardiac and of vascular hypertrophy and hyperplasia

Info

Publication number
ZA906327B
ZA906327B ZA906327A ZA906327A ZA906327B ZA 906327 B ZA906327 B ZA 906327B ZA 906327 A ZA906327 A ZA 906327A ZA 906327 A ZA906327 A ZA 906327A ZA 906327 B ZA906327 B ZA 906327B
Authority
ZA
South Africa
Prior art keywords
treatment
hyperplasia
cardiac
administration
vascular hypertrophy
Prior art date
Application number
ZA906327A
Other languages
English (en)
Inventor
Wolfgang Linz
Linz Wolfgang
Hansjoerg Urbach
Urbach Hansjoerg
Rainer Henning
Henning Rainer
Bernward Schoelkens
Schoelkens Bernward
Wolfgang Scholz
Scholz Wolfgang
Volker Teetz
Teetz Volker
Gabriele Wiemer
Wiemer Gabriele
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6386970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA906327(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA906327B publication Critical patent/ZA906327B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preliminary Treatment Of Fibers (AREA)
  • Crucibles And Fluidized-Bed Furnaces (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Element Separation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA906327A 1989-08-11 1990-08-10 A method for the treatment of cardiac and of vascular hypertrophy and hyperplasia ZA906327B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3926606A DE3926606A1 (de) 1989-08-11 1989-08-11 Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie

Publications (1)

Publication Number Publication Date
ZA906327B true ZA906327B (en) 1991-05-29

Family

ID=6386970

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906327A ZA906327B (en) 1989-08-11 1990-08-10 A method for the treatment of cardiac and of vascular hypertrophy and hyperplasia

Country Status (22)

Country Link
US (1) US5231083A (cs)
EP (1) EP0417473B1 (cs)
JP (1) JP3452199B2 (cs)
KR (1) KR0185969B1 (cs)
AT (1) ATE94409T1 (cs)
AU (1) AU631914B2 (cs)
CA (1) CA2023089C (cs)
CS (1) CS277644B6 (cs)
DD (1) DD297063A5 (cs)
DE (2) DE3926606A1 (cs)
DK (1) DK0417473T3 (cs)
ES (1) ES2059931T3 (cs)
FI (1) FI903936A7 (cs)
HU (1) HU205008B (cs)
IE (1) IE64604B1 (cs)
IL (1) IL95327A (cs)
NO (1) NO306979B1 (cs)
NZ (1) NZ234836A (cs)
PH (1) PH30831A (cs)
PL (1) PL286442A1 (cs)
PT (1) PT94957B (cs)
ZA (1) ZA906327B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0682947B1 (en) 1994-05-19 1997-09-10 Mitsubishi Chemical Corporation Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia
SG68529A1 (en) * 1995-05-25 1999-11-16 Univ Singapore The use of des-aspartate-angiotensin i (agr-val-tyr-ile-his-pro-phe-his-leu) as an anti-cardiac hypertrophic agent
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
PL353199A1 (en) * 1999-08-30 2003-11-03 Aventis Pharma Deutschland Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
AU2005304664A1 (en) * 2004-11-05 2006-05-18 King Pharmaceuticals Research & Development, Inc. Stabilized ramipril compositions and methods of making
JP5951625B2 (ja) 2010-11-24 2016-07-13 ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨークＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｃｏｌｕｍｂｉａ Ｕｎｉｖｅｒｓｉｔｙ Ｉｎ Ｔｈｅ Ｃｉｔｙ Ｏｆ Ｎｅｗ Ｙｏｒｋ 加齢性黄斑変性症およびシュタルガルト病の処置のための非レチノイドｒｂｐ４アンタゴニスト
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
EP2968303B1 (en) 2013-03-14 2018-07-04 The Trustees of Columbia University in the City of New York Octahydrocyclopentapyrroles, their preparation and use
WO2014151936A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles, their preparation and use
EP2968304B1 (en) 2013-03-14 2018-10-10 The Trustees of Columbia University in the City of New York 4-phenylpiperidines, their preparation and use
WO2014151959A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
WO2015168286A1 (en) 2014-04-30 2015-11-05 The Trustees Of Columbia University In The City Of New York Substituted 4-phenylpiperidines, their preparaiton and use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4311705A (en) * 1980-10-06 1982-01-19 E. R. Squibb & Sons, Inc. Carboxyalkanoyl and hydroxycarbamoylalkanoyl derivatives of substituted prolines
US4337201A (en) * 1980-12-04 1982-06-29 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted prolines
US4381297A (en) * 1981-05-04 1983-04-26 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
US4602002A (en) * 1983-02-07 1986-07-22 Merck & Co., Inc. N-carboxymethyl substituted lysyl and α-(ε-aminoalkyl) glycyl amino acid antihypertensive agents
US4548941A (en) * 1984-07-30 1985-10-22 Merck & Co., Inc. 1,5-Methano-1H-4-benzazonine dicarboxylates, process for preparing and use as calcium blockers
US4587253A (en) * 1984-07-30 1986-05-06 Merck & Co., Inc. Bridged pyridine compounds useful as calcium channel blockers and analgesics
US4599341A (en) * 1984-10-01 1986-07-08 Merck & Co., Inc. Substituted and bridged pyridines useful as calcium channel blockers
US4656188A (en) * 1985-10-09 1987-04-07 Merck & Co., Inc. Ace inhibitors in macular degeneration
DE3705220A1 (de) * 1987-02-19 1988-09-01 Boehringer Ingelheim Kg Mittel zur behandlung von coronarerkrankungen oder organischem hirnsyndrom
ZA896851B (en) * 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors

Also Published As

Publication number Publication date
PT94957A (pt) 1991-05-22
IE902910A1 (en) 1991-02-27
ATE94409T1 (de) 1993-10-15
US5231083A (en) 1993-07-27
HUT54504A (en) 1991-03-28
IL95327A (en) 1995-10-31
KR0185969B1 (ko) 1999-05-01
DD297063A5 (de) 1992-01-02
NZ234836A (en) 1997-05-26
PT94957B (pt) 1997-05-28
JP3452199B2 (ja) 2003-09-29
DE59002721D1 (de) 1993-10-21
NO903532L (no) 1991-02-12
IL95327A0 (en) 1991-06-30
KR910004189A (ko) 1991-03-28
FI903936A7 (fi) 1991-02-12
FI903936A0 (fi) 1990-08-09
AU6092090A (en) 1991-02-14
HU205008B (en) 1992-03-30
EP0417473B1 (de) 1993-09-15
CA2023089C (en) 2003-01-14
NO306979B1 (no) 2000-01-24
NO903532D0 (no) 1990-08-10
DK0417473T3 (da) 1993-12-13
CS395890A3 (en) 1992-08-12
IE64604B1 (en) 1995-08-23
EP0417473A1 (de) 1991-03-20
CA2023089A1 (en) 1991-02-12
JPH0383957A (ja) 1991-04-09
CS277644B6 (en) 1993-03-17
DE3926606A1 (de) 1991-02-14
PH30831A (en) 1997-10-17
ES2059931T3 (es) 1994-11-16
PL286442A1 (en) 1992-03-09
HU904966D0 (en) 1991-01-28
AU631914B2 (en) 1992-12-10

Similar Documents

Publication Publication Date Title
SG43768A1 (en) Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative dieases
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
SE8503680D0 (sv) Indolderivat
PH30831A (en) Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia.
HU895815D0 (en) Insecticide compositions containing heterocyclic compounds and process for the preparation of such compounds
EP0219782A3 (en) Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease
DE3478810D1 (en) Benzazocinone and benzazoninone derivatives, process for their preparation, pharmaceutical preparations containing these compounds, and their therapeutical use
ES2108717T3 (es) Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
NO165921C (no) Fremgangsmaate for fremstilling av disubstituerte prolinderivater.
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
NO891703D0 (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
HUT37797A (en) Process for production of tetrahydro-tieno-piridinderivatives and medical preparatives containing of such compounds
DK440987A (da) Thyroninderivater, deres fremstilling og anvendelse
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
ATE80388T1 (de) Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.
ES2040750T3 (es) Un procedimiento para la preparacion de un derivado de isoquinolinol.
EP0295350A3 (en) Use of n-û2-(diethylamino)ethyl¨-2-methoxy-4-û(1-h 4,5-dihydro-2-imidazolyl)amino¨-5-chlorobenzamide as an anxiolytic and antipsychotic agent
NO880405D0 (no) Fremgangsmaate til fremstilling av 3-fenyl-7h-tiazolo-/3,2-b//1,2,4/-tiazine-7-oner.